Sources
Bank changelog
The evidence bank is versioned like software. Every plan stamps the bank version it was built from, every rule carries a review-due date, and when a guideline publishes a new edition the citing rules get flagged for re-review instead of silently migrating.
Version history (current: 0.3.0)
v0.3.0
2026-06-23current
Evidence currency pass: cite Dietary Guidelines for Americans 2025-2030 and the 2026 AHA dietary guidance; refresh AHA sodium wording; added sugar reframed to no more than 10 g per meal; co-cite KDIGO 2024 on CKD sodium; recalibrate metformin-B12, statin-grapefruit, and potassium-caution grades.
v0.2.0
2026-06-22Clinical sign-off by Dr. J. Bakhos. Saturated fat shown as a <6% goal with <10% upper limit; HTN sodium capped at 2,300 mg with 1,500 mg noted as ideal; CKD protein branched by diabetes status (KDOQI 3.0.1/3.0.2); SGLT2 ketoacidosis caution split into ADA-verbatim + separately-cited ketogenic-diet note.
v0.1.0
2026-06-22Initial seed: cardiometabolic + CKD G1–3b rules, core safety gates, drug–nutrient interactions, and starter recipe set. All web-sourced; pending clinical sign-off.
Review schedule, every rule
Plant-forward foundation
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
Type 2 diabetes nutrition therapy
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
Prediabetes nutrition
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
Hypertension - sodium reduction & DASH pattern
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
Dyslipidemia / CVD risk - limit saturated fat
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
Overweight / obesity - nutrient-dense pattern
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
CKD - sodium limit
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
CKD G3 - protein target (without diabetes)
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
CKD G3 - protein target (with diabetes)
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
CKD G3 - potassium limit with a potassium-raising medication
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
CKD G3 - phosphorus / additives
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
Warfarin - keep vitamin K consistent
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
Statin (CYP3A4) - avoid grapefruit
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
ACEi / ARB / K-sparing diuretic - hyperkalemia caution
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
MAO inhibitor - avoid tyramine
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
Metformin - vitamin B12 monitoring
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
SGLT2 inhibitor - ketoacidosis caution
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
Diuretics - follow prescriber diet instructions
effective 2026-06-22 · review due 2027-06-22
signed off 2026-07-07
GLP-1 therapy - nutrition support
effective 2026-06-22 · review due 2027-06-22
signed off 2026-07-07
Levothyroxine - separation & timing
effective 2026-06-22 · review due 2027-06-22
signed off 2026-06-22
MASLD / fatty liver - Mediterranean pattern, less sugar and alcohol
effective 2026-06-29 · review due 2027-06-29
signed off 2026-07-07
Gout - limit alcohol, purines, and high-fructose corn syrup
effective 2026-06-29 · review due 2027-06-29
signed off 2026-07-07
Cancer risk reduction - plant-forward, less red and processed meat
effective 2026-06-29 · review due 2027-06-29
signed off 2026-07-07
Diverticular disease - high-fiber prudent pattern
effective 2026-06-29 · review due 2027-06-29
signed off 2026-07-07
Rules past their review-due date are withheld from plans until re-reviewed. Nothing is hard-deleted; superseded entries keep their history.